| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |